134 related articles for article (PubMed ID: 36481361)
1. UBE2K promotes the malignant progression of hepatocellular carcinoma by regulating c-Myc.
Lei X; Hu X; Lu Q; Yao Y; Sun W; Ma Q; Huang D; Xu Q
Biochem Biophys Res Commun; 2023 Jan; 638():210-218. PubMed ID: 36481361
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia-induced UBE2K promotes the malignant progression of HCC.
Ouyang G; Fu W; Guo J; Lu Q; Yao Y; Ge L; Zhao J; Zhang J; Hu X; Li S; Xu Q; Huang D; Zhang Y
Pathol Res Pract; 2023 May; 245():154422. PubMed ID: 37003132
[TBL] [Abstract][Full Text] [Related]
3. N6-Methyladenosine Modification and Prognostic Analysis of UBE2K in Hepatocellular Carcinoma: A Potential Target.
Guo J; Zhao J
Crit Rev Eukaryot Gene Expr; 2023; 33(8):41-55. PubMed ID: 37606163
[TBL] [Abstract][Full Text] [Related]
4. LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling.
Liu J; Xu R; Mai SJ; Ma YS; Zhang MY; Cao PS; Weng NQ; Wang RQ; Cao D; Wei W; Guo RP; Zhang YJ; Xu L; Chen MS; Zhang HZ; Huang L; Fu D; Wang HY
Theranostics; 2020; 10(17):7527-7544. PubMed ID: 32685003
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of ubiquitin-specific peptidase 13 inhibits cell growth of hepatocellular carcinoma by reducing c-Myc expression.
Huang J; Gu ZL; Chen W; Xu YY; Chen M
Kaohsiung J Med Sci; 2020 Aug; 36(8):615-621. PubMed ID: 32255563
[TBL] [Abstract][Full Text] [Related]
7. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
8. Mild chronic hypoxia-induced HIF-2α interacts with c-MYC through competition with HIF-1α to induce hepatocellular carcinoma cell proliferation.
Mu H; Yu G; Li H; Wang M; Cui Y; Zhang T; Song T; Liu C
Cell Oncol (Dordr); 2021 Oct; 44(5):1151-1166. PubMed ID: 34339013
[TBL] [Abstract][Full Text] [Related]
9. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
10. Hematological and neurological expressed 1 (HN1) activates c-Myc signaling by inhibiting ubiquitin-mediated proteasomal degradation of c-Myc in hepatocellular carcinoma.
Feng J; Liu Y; Fang T; Zhu J; Wang G; Li J
Cell Biol Int; 2023 Mar; 47(3):560-572. PubMed ID: 36403281
[TBL] [Abstract][Full Text] [Related]
11. TXNDC9 promotes hepatocellular carcinoma progression by positive regulation of MYC-mediated transcriptional network.
Chen D; Zou J; Zhao Z; Tang X; Deng Z; Jia J; Liu S
Cell Death Dis; 2018 Oct; 9(11):1110. PubMed ID: 30382079
[TBL] [Abstract][Full Text] [Related]
12. PTTG1 is involved in TNF-α-related hepatocellular carcinoma via the induction of c-myc.
Lin X; Yang Y; Guo Y; Liu H; Jiang J; Zheng F; Wu B
Cancer Med; 2019 Sep; 8(12):5702-5715. PubMed ID: 31385458
[TBL] [Abstract][Full Text] [Related]
13. ID1 overexpression promotes HCC progression by amplifying the AURKA/Myc signaling pathway.
Wu M; Zhou Y; Fei C; Chen T; Yin X; Zhang L; Ren Z
Int J Oncol; 2020 Sep; 57(3):845-857. PubMed ID: 32705157
[TBL] [Abstract][Full Text] [Related]
14. UBE2O promotes hepatocellular carcinoma cell proliferation and invasion by regulating the AMPKα2/mTOR pathway.
Shi Z; Liu R; Lu Q; Zeng Z; Liu Y; Zhao J; Liu X; Li L; Huang H; Yao Y; Huang D; Xu Q
Int J Med Sci; 2021; 18(16):3749-3758. PubMed ID: 34790050
[TBL] [Abstract][Full Text] [Related]
15. The splicing regulatory factor hnRNPU is a novel transcriptional target of c-Myc in hepatocellular carcinoma.
Zhang B; Wang HY; Zhao DX; Wang DX; Zeng Q; Xi JF; Nan X; He LJ; Zhou JN; Pei XT; Yue W
FEBS Lett; 2021 Jan; 595(1):68-84. PubMed ID: 33040326
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic hsa_circ_0091581 promotes the malignancy of HCC cell through blocking miR-526b from degrading c-MYC mRNA.
Wei X; Zheng W; Tian P; He Y; Liu H; Peng M; Li X; Liu X
Cell Cycle; 2020 Apr; 19(7):817-824. PubMed ID: 32116112
[TBL] [Abstract][Full Text] [Related]
17. CircRNA UBAP2 serves as a sponge of miR-1294 to increase tumorigenesis in hepatocellular carcinoma through regulating c-Myc expression.
Yu MC; Ding GY; Ma P; Chen YD; Zhu XD; Cai JB; Shen YH; Zhou J; Fan J; Sun HC; Kuang M; Huang C
Carcinogenesis; 2021 Oct; 42(10):1293-1303. PubMed ID: 34314478
[TBL] [Abstract][Full Text] [Related]
18. UBE2K regulated by IGF2BP3 promotes cell proliferation and stemness in pancreatic ductal adenocarcinoma.
Fu W; Lei X; Lu Q; Zhang J; Guo J; Zhao J; Tong X; Hu X
Int J Oncol; 2023 Apr; 62(4):. PubMed ID: 36896783
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-216b suppresses the cell growth of hepatocellular carcinoma by inhibiting Ubiquitin-specific peptidase 28 expression.
Zhang JF
Kaohsiung J Med Sci; 2020 Jun; 36(6):423-428. PubMed ID: 32053284
[TBL] [Abstract][Full Text] [Related]
20. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
